| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.82T | 9.66T | 8.77T | 5.78T | 3.80T |
| Gross Profit | 5.87T | 4.72T | 4.16T | 3.51T | 3.15T |
| EBITDA | 2.70T | 1.98T | 1.64T | 1.37T | 1.17T |
| Net Income | 1.68T | 1.18T | 962.95B | 805.84B | 706.63B |
Balance Sheet | |||||
| Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Cash, Cash Equivalents and Short-Term Investments | 90.83T | 10.00T> | 10.00T> | 75.91T | 74.79T |
| Total Debt | 58.66T | 58.30T | 34.26T | 46.16T | 32.12T |
| Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Stockholders Equity | 15.85T | 14.70T | 14.66T | 12.68T | 12.10T |
Cash Flow | |||||
| Free Cash Flow | 7.34T | 4.60T | 250.98B | -6.19T | 1.26T |
| Operating Cash Flow | 7.54T | 4.97T | 642.86B | -5.90T | 1.55T |
| Investing Cash Flow | -21.91T | -4.51T | -918.90B | 5.93T | -2.41T |
| Financing Cash Flow | 6.83T | -480.15B | 280.69B | -357.78B | -485.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $321.13B | 14.15 | 12.07% | 4.14% | -6.12% | 12.49% | |
70 Outperform | $146.71B | 15.01 | 10.37% | 2.54% | 4.88% | 39.26% | |
68 Neutral | $219.31B | 14.53 | 11.49% | 2.48% | 3.82% | 34.94% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $222.82B | 14.68 | 7.53% | 1.94% | 3.02% | 27.74% | |
65 Neutral | $240.78B | 11.94 | 12.04% | 1.80% | 1.28% | 16.35% | |
64 Neutral | $180.25B | 9.75 | 15.73% | 1.85% | -14.46% | 36.76% |